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Castleman’s disease is a rare benign lymphoproliferative disorder, characterized by benign growths of the
lymph node tissue. It is associated with a number of malignancies, including Kaposi sarcoma, non-
Hodgkin’s and Hodgkins lymphoma, and POEMS syndrome. This report describes the case of a 38 year
old gentleman, presenting with painless hematuria. Initial investigations, including ﬂexible cystoscopy
were unremarkable. However, subsequent imaging including CT Urogram and MR pelvis revealed mul-
tiple prevesical lesions. Histology obtained from excision biopsy revealed histological features consistent
with Castleman’s disease. In this report we discuss the nature, presentation and treatment modalities of
this rare condition.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).A 38 year old gentleman was referred to the Urology clinic in
early October 2012 with painless hematuria. He had no signiﬁcant
medical or surgical history, other than being investigated for
obstructive sleep apnea. Initial investigations were normal,
including full blood count, renal proﬁle, urine microscopy and
cytology. Upon ﬂexible cystoscopy in the clinic, there were no
obvious abnormalities, the urethral mucosa appeared normal, both
ureteric oriﬁces were clearly visible, the trigonal region appeared
normal, and there was no focal mucosal bladder pathology. It was
noted that there was some extrinsic compression on the posterior
bladder wall at cystoscopy. Ultrasound scan of the pelvis revealed
an echogenic area over the anterior bladder wall. These abnor-
malities were further investigated with a CT Urogram which was
performed within the following weeks.
The CT scan revealed evidence of multiple prevesical soft tissue
nodules, the largest of which measuring 2.6  1.3 cm (Figs. 1 and 2).
The remainder of the abdominal organs were reported as
completely normal, of particular importance in this case, there was
no evidence of any hydronephrosis, calculi, extrinsic compression
or bladder mucosal abnormality. The exact nature of these nodules
remained unclear, and the possibility of atypical lymph nodes or
urachal remnants were discussed at a Multi-Disciplinary Team
(MDT) meeting.
The MDT deemed that a repeat scan would be indicated in
3 months from that time, as the lesions were most likely to beari).
Inc. This is an open access article ubenign. As a result of this decision an MRI scan of the pelvis was
performed in December 2012, this again was reported as showing
multiple soft tissue nodules that were essentially unchanged from
the previous CT ﬁndings (Fig. 3).
The case was again discussed at MDT, whom deemed that his-
tological sampling via excisional biopsy of the prevesical lesions
would be the most appropriate modality for diagnosis. This was
performed in May/2013 under a general anesthetic.
The histology report revealed ﬁbro-fatty connective tissue with
lymphoid inﬁltrate which were in keeping with features of Cas-
tleman’s disease (hyaline vascular variant). Further immunohisto-
chemistry revealed positive BCL2 expression excluding lymphoma
and conﬁrming Castleman’s disease.
Castleman’s disease (giant or angiofollicular lymph node hy-
perplasia) is a rare benign lymphoproliferative disorder that may be
localized to a single lymph node (unicentric) or multifocal/systemic
(multicentric).1 It is characterized by benign growths of the lymph
node tissue, and can also involve lymphoproliferation of B cells,
with stimulation and production of certain pro-inﬂammatory cy-
tokines, such as interleukin-6 (IL-6).2 It is also associated with a
number of malignancies, including Kaposi sarcoma, non-Hodgkin
lymphoma, Hodgkin lymphoma, and POEMS syndrome.
As mentioned above, Castleman’s disease can be categorized
into two distinct types of disease. Unicentric Castleman’s disease
(UCD) involves lymphoproliferation of tissue at a single lymph node
site.3 It is often asymptomatic or has very few symptoms other than
those directly associated with a local mass affect from direct
compression of surrounding tissues by the lymph node, as was
found in the case above. The majority of cases can be cured viander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Figure 1. Transverse CT slice demonstrating prevesical lymphoid lesion.
Figure 2. Sagittal CT slice demonstrating prevesical lymphoid lesions.
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plications or local recurrence.
Multicentric Castleman’s disease (MCD) is distinguished from
UCD by the multi focal nature of its presentation.4 There will often
be multiple lymph nodes involved at different tissue sites. It is not
classiﬁed as malignant and therefore differs from lymphoma,
however it does share similarities with lymphoma, and in fact, may
even progress into lymphoma. This type of Castleman’s disease is
more common amongst immunosuppressed patients, as it has been
identiﬁed in approximately 50% of cases with human herpes virus 8
(HHV-8), a gammaherpesvirus that is also the cause of Kaposi’s
sarcoma and primary effusion lymphoma.4,5 The remaining 50% of
cases are of unknown causes. The histological form of MCD most
closely associated with HHV-8 is the plasmacytic form of Castle-
man’s disease while another histological form, the hyaline-vascular
type is often found to be negative for herpes virus. Symptoms of
MCD are more common than those of UCD, as a result of the over
expression of cytokines. These symptoms may include “B symp-
toms” similar to those with lymphoma, which involve; pyrexia,
weight loss, anemia and loss of appetite, all of which may to be due
to the overproduction of IL-6.2
Castleman’s disease can also be categorized into histological
subtypes. The hyaline vascular type is most common. It tends to be
localized, but in rare cases can be multicentric. In addition, the
plasma cell type is slightly more likely to be multicentric. There is
also mixed histological subtype that illustrates characteristics of
both cell types. This is the least common subtype.Figure 3. Transverse MR slice demonsUnicentric disease can often be treated easily with surgical
resection.4
Treatment of MCD is often a little more complex, secondary to
the systemic nature of the disease. Treatment modalities include
antiviral drugs for human herpes virus type 8 (HHV-8), various
immunomodulators, corticosteroids, chemotherapy, and more
recently;monoclonal antibodies against IL-6 or B-cells themselves.2
Recent work with HIV-positive patients with HHV-8-related
MCD suggests that treatment with the antiherpesvirus drug gan-
ciclovir or the anti-CD20 B cell monoclonal antibody, rituximab,
maymarkedly improve outcome.4 Due to the rarity of MCD, there is
a paucity of evidence that has addressed standardized approaches
to therapy.
The above case outlines a rare example of unicentric Castleman’s
disease. The patient described was essentially asymptomatic other
than painless hematuria. The ﬁndings were incidental on CT/MR
scanning. The treatment modality here was surgical resection via
excisional biopsy. Whether or not this patient will go on to develop
any post-operative complications or local recurrence will become
apparent during the follow up period, which is planned on an
annual basis.trating prevesical lymphoid lesion.
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